Strong cooperation jointly promote the high-quality development of Chinese brands in the global market

 

Shenzhen Mindray bio-medical electronics Co., Ltd., China Meheco Corporation and China Export & Credit Insurance Corporation signed a tripartite cooperation strategic agreement in Beijing, aiming to further broaden the field of cooperation and optimize the allocation of resources, and jointly improve the international influence of Chinese brands. The three parties signed a strategic cooperation agreement in Beijing, aiming to further broaden the field of cooperation, optimize the allocation of resources, and jointly improve the international influence of Chinese brands.

Sansure expects first-half revenue to increase by more than 60% year-on-year

Sansure Biotech disclosure results forecast, is expected to achieve operating income of RMB 710 million in the first half of the year, up 66% year-on-year; mother net profit of RMB 150 million to 165 million, up 64% to 80%; deducted net profit of RMB 120 million to 130 million, up 285% to 317% year-on-year.

 

In the first half of this year, Sansure Biotech continued to drive by the dual-wheel drive of ‘innovation + service’, and steadily pushed forward the strategy of platformization and internationalization, to further consolidate and enhance the technological and market advantages in the field of in-vitro diagnostics, and demonstrated strong growth potential. 

Xiangjiang Laboratory and BGI sign strategic cooperation agreement

 

Xiangjiang Lab signed a strategic cooperation agreement with BGI. The two sides will carry out long-term, stable and in-depth scientific and technological innovation and synergistic cooperation around scientific research and platform construction, cultivation of new engineering and new business talents, and transformation of scientific and technological achievements.

New breakthrough in NGS kits

Meridian Bioscience recently announced the launch of the first lyophilized NGS library kit on the global market. This groundbreaking product emphasizes Meridian Bioscience's commitment to sustainable and cost-effective solutions for the life sciences industry. Combined with the launch of the glycerol-free NGS library building molecular enzyme product line in April of this year, Meridian Bioscience is well on its way to becoming an industry leader in the development of innovative, environmentally friendly, cost-effective diagnostic tests.

Indonesian BPOM and KGbio Visit Henlius

 

Recently, a delegation led by Ms. Lucia Rizka Andalucia, Acting Head of Indonesia’s National Agency for Drug and Food Control (BPOM), accompanied by Sie Djohan, President Director of PT Kalbe Genexine Biologics (KGbio), visited Henlius. Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius, warmly received the delegation and extended a sincere welcome.